13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
| Image |  |
|---|---|
| Description | scientific article published on 23 March 2015 |
| Author/s |
author: Baba Inusa Alberto E. Tozzi Natasha B. Halasa William C. Gruber Paul Heath |
| Publication date | March 23, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |